S. S. Burtcev

S. S. Burtcev

Auto-generated profile, based on publicly available information

S. S. Burtcev

FSBEI HE “Rostov State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Venous Disorders
Verified
Journal Article
Closed access
AKA.G. Khitaryan
A.G. Khitaryan
SBS.S. Burtsev
S.S. Burtsev
AOA.A. Orekhov
A.A. Orekhov
KVK.S. Veliev
K.S. Veliev
ALA.A. Ledenev
A.A. Ledenev
Проведен обзор зарубежной и отечественной литературы по проблеме хронических заболеваний вен (ХЗВ) при морбидном ожирении. Поиск источников осуществлен в базах данных PubMed, Cochrane за период с 1986 по 2020 г. Все работы, представленные в обзоре литературы, имеют особую значимость для исследуемой темы. Во всех указанных публикациях под морбидным ожирением подразумевается индекс массы тела (ИМТ) >40 кг/м2. В статье с разных позиций рассматриваются вопросы эпидемиологии ХЗВ и ожирения; основные аспекты патогенеза хронической венозной недостаточности (ХВН) у больных, страдающих морбидным ожирением; особенности клинического течения ХВН; вопросы, касающиеся гемодинамических параметров венозного кровотока нижних конечностей у пациентов с избыточной массой тела и с морбидным ожирением; тактические подходы к лечению ХВН; роль бариатрической хирургии и минимально инвазивных вмешательств в лечении этой категории больных. Показано, что ожирение является одним из ведущих факторов риска возникновения и основным предиктором всех типов венозной патологии. На сегодняшний день общепризнанным мировым трендом и наиболее эффективным методом по борьбе с ожирением является бариатрическая хирургия. На данный момент многие вопросы, связанные с ХВН и ожирением, остаются открытыми, что обусловливает острую необходимость в дальнейших масштабных проспективных рандомизированных исследованиях по изучению вопроса влияния снижения массы тела посредством бариатрической хирургии на эффективность лечения разных форм ХВН.

3 November 2021 in Grekov's Bulletin of Surgery
Verified
Journal Article
Open access
PDF file
AKA. G. Khitaryan
A. G. Khitaryan
BKB. B. Khatsiev
B. B. Khatsiev
AMA. V. Mezhunts
A. V. Mezhunts
ASA. V. Sarkisyan
A. V. Sarkisyan
ДМД. А. Мельников
Д. А. Мельников
SBS. S. Burtcev
S. S. Burtcev
INTRODUCTION. Bariatric operations lead to changes in body composition. The desired fat loss may be accompanied by decrease of muscle mass, thus raising the risk of sarcopenia.The OBJECTIVE was to evaluate the long-term results of surgical treatment of morbid obesity and concomitant comorbid conditions, as well as a decrease of muscle mass in the pre - and long-term postoperative period.METHODS AND MATERIALS. This prospective randomized controlled blind trial included the results of treatment of 241 patients. Patients were divided into 2 groups depending on the type of surgical treatment. The first group consisted of 116 people who underwent RYGB; the second group included 125 patients who underwent OAGB/MGB. 83 patients from the first group and 95 patients from the control group at the preoperative stage and 24 months after the operation randomly underwent bioelectrical impedance with the determination of skeletal muscle mass (SMM) and skeletal muscle mass index (SMMI)=SMM/Height2. The calculated SMMI index for men normally corresponds to >10.76 kg/m2; moderate sarcopenia SMMI=8.51–10.75 kg/m2; the SMMI index of ≤8.5 kg/m2 corresponds to severe sarcopenia. For women, this index is normally ≥6.76 kg/m2; moderate – 5.76–6.75 kg/m2; severe sarcopenia ≤5.75 kg/m2. Bioelectrical impedance were performed on a «AVS-01 Medass» bioelectrical impedance body composition analyzer (Russia). RESULTS. The difference in changes in the results of anthropometric indicators, as well as laboratory indicators of diabetes compensation within 24 months in both groups was statistically insignificant (p>0.05). According to bioelectrical impedance data, the incidence of sarcopenia in patient groups was as follows: the initially normal ratio of muscle mass to the square of growth in meters, i.e. normal SMMI in 71 (85.5 %) patients in the group with RYGB, and in 78 (85.7 %) patients in the group with OAGB/MGB. Moderate sarcopenia was detected in 12 (14.5 %) patients with RYGB and 13 (14.3 %) patients with OAGB/MGB. 24 months after the operation, SMMI was distributed as follows – Norm in 59 (71.1 %) patients of the study group and 47 (51.6 %) patients in the control group. Moderate sarcopenia was found in 16 (19.3 %) patients in the group of patients with RYGB, and in 29 (31.9 %) cases in the group of patients with OAGB/MGB. Severe sarcopenia was observed in 8 (9.6 %) patients of the first group and 15 (16.5 %) patients of the second group (p=0.0001).CONCLUSIONS. Bariatric bypass surgery results in significant changes in body composition 24 months after surgery. Bioelectrical impedance allows to effectively detect these changes. The desired weight loss is associated with a significant decrease in skeletal muscle mass, mineral mass. Thus, patients after bypass surgery are at risk of sarcopenia. Sarcopenia is more pronounced in patients after OAGB/MGB than after RYGB.

12 June 2022 in Koloproktologia
Verified
Journal Article
Open access
PDF file
AKA. G. Khitaryan
A. G. Khitaryan
AGA. A. Golovina
A. A. Golovina
SKS. A. Kovalev
S. A. Kovalev
SBS. S. Burtsev
S. S. Burtsev
   Aim:  to assess the efficacy and safety of laparoscopic ventral mesh rectopexy in patients with rectocele and rectal prolapse.   Materials and methods: a systematic review of the literature on the efficacy and safety of laparoscopic ventral mesh rectopexy in patients with rectocele and/or rectal prolapse. After compiling a search query, 2716 publications were found in the PubMed, MEDLINE, EMBASE, Scopus, Cochrane library, CENTRAL, ISI Web of Science and eLibrary databases. Twenty-four papers were selected according to the inclusion criteria for the review, with a total number of 2101 operated patients.   Results: the follow up period after surgery ranged 30.1 (12-74) months. In 20 of 34 studies, the median age of patients was over 60 years, with a median of 62.1 years. The mean operative time was 122.3 minutes (85 to 200 minutes). Complications were revealed in 138 patients (6.5 % observations), recurrence — in 4.1 %. A significant improvement in the symptoms of obstructive defecation was noted in 79.6 %.   Conclusion: laparoscopic ventral mesh rectopexy is an effective method for posterior pelvic floor compartment prolapse in terms of both anatomical and functional results. It is safe and has a low risk of complications. However, further research is required to develop indications for the use of this proctdure as a “gold standard”.